Anthropic on Tuesday launched Claude Science, an AI platform designed to help scientists streamline research, analyze data and manage complex computing workflows.
The launch is part of Anthropic’s life sciences and healthcare initiative, which the IPO-bound company has been developing since October 2025.
Here are a few details on the launch:
Claude Science combines databases, coding tools, compute and research workflows in one workspace, helping scientists analyze literature, run analyses, create figures and manuscripts, and trace results back to their source code and environment.
The tool is pre-configured with more than 60 scientific databases and can render scientific artifacts such as 3D protein structures, genome browser tracks and chemistry drawings, Anthropic said.
Claude Science runs on Anthropic’s existing Claude models, which have undergone the company’s standard responsible scaling and biosecurity evaluations.
Several research organizations and companies testing the platform in beta reported significant efficiency gains, Anthropic added.
Anthropic is also launching its own pre-clinical drug programmes, focused on neglected diseases, the AI startup’s head of life sciences Eric Kauderer-Abrams said during a press briefing.
“These are areas that are outside the scope of what the traditional pharma and biotech landscape might consider attractive targets, but nonetheless have real burden associated with them,” Kauderer-Abrams said.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
